NDC 13985-222 - Lidocaine 2%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-222
- Package NDCs from labels
- 13985-222-04, 13985-222-05
- Manufacturer
- MWI/VetOne
- Effective date
- 2020-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine 2% - MWI/VetOne | MWI/VetOne | 2020-02-14 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-222-04 | Lidocaine2% | 100 mL in 1 BOTTLE | INJECTION | 100 | 4 | |
| 13985-222-05 | Lidocaine2% | 250 mL in 1 BOTTLE | INJECTION | 250 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | LIDOCAINE 2% (LIDOCAINE) INJECTION [MWI/VETONE] | 2 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE 2% (LIDOCAINE) INJECTION [MWI/VETONE] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bruselix Cream | LIDOCAINE HCI 3.88% | PureTek Corporation | 1510163f-b7fd-2e17-e063-6394a90a1799 | 2024-04-05 | Warnings, Adverse reactions | V13007Z41A |
| Bruselix Gel | LIDOCAINE HCI 3.88% | PureTek Corporation | 1420ec27-64f3-9117-e063-6294a90a8ece | 2024-04-05 | Warnings, Adverse reactions | V13007Z41A |
| First Aid Antiseptic Pain Relieving Benzalkonium Chloride Lidocaine Hydrochloride | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | M-star (Hubei) Health&Care Products Co., Ltd. | 8e1f35ff-d4e6-4940-ad8f-dce2b73e595d | 2024-04-01 | Warnings | V13007Z41A |
| Lidotral 5 Percent and Hydrocortisone 1 Percent with Peptides and Arnica | LIDOCAINE HCL 5 % , HYDROCORTISONE ACETATE 1% | PureTek Corporation | 0d871371-91ca-9ad7-e063-6294a90a5907 | 2024-03-15 | Warnings, Adverse reactions | V13007Z41A |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co. LLC, DBA Health First | 74450548-62f4-b77f-e053-2991aa0ae5cf | 2024-03-08 | Warnings, Adverse reactions | V13007Z41A |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | 1308ce91-2858-310a-e063-6394a90a6810 | 2024-03-06 | Warnings | V13007Z41A |
| Numquick Analgesic | EPINEPHRINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE | Unit Dose, Ltd. | b66e7a91-9e35-64dd-e053-2a95a90a8b83 | 2024-02-28 | Warnings | V13007Z41A |
| Lidotral 3.88% Roll on | LIDOCAINE HCI | PureTek Corporation | db1085fe-0a1f-c4cc-e053-2a95a90aa838 | 2024-02-28 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HCI AND EPINEPHRINE | LIDOCAINE HCI AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 957506a5-1b09-0736-e053-2995a90a0b63 | 2024-02-26 | Warnings, Adverse reactions | V13007Z41A |
| SunBurnt PLUS | LIDOCAINE HYDROCHLORIDE | Quest Products, LLC. | 12128c75-015d-8a72-e063-6394a90ae00a | 2024-02-23 | Warnings | V13007Z41A |
| LIDOCAINE HCl AND EPINEPHRINE | LIDOCAINE HCL AND EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | a098ab6c-143f-77a5-e053-2a95a90a3e0a | 2024-02-22 | Warnings, Adverse reactions | V13007Z41A |
| Kroger Analgesic Analgesic | LIDOCAINE HYDROCHLORIDE | THE KROGER CO | e6c5ead3-87d0-48ed-a4dc-86cf89ebb285 | 2024-02-22 | Warnings | V13007Z41A |
| LIDOCAINE HCl | LIDOCAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | c1735498-0721-687c-e053-2a95a90a47f4 | 2024-02-19 | Warnings, Adverse reactions | V13007Z41A |
| 1168 | 1168 BURN SPRAY | Dynarex Corporation | 1183a4f5-f875-dfb0-e063-6394a90af35f | 2024-02-16 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 0050d05a-b8e9-c544-e063-6294a90a0243 | 2024-02-08 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 1c5eb3b3-79b3-472a-ae36-ec6a7dc72925 | 2024-02-07 | Warnings | V13007Z41A |
| Antiseptic | ALCOHOL, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 71aeaf86-2b4d-4945-9606-a9db0ab6b726 | 2024-02-07 | Warnings | V13007Z41A |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 47cb6921-5d82-4123-a9e0-0b05d4dcb5b2 | 2024-02-07 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Safetec of America, Inc. | 8eb3e7e2-26e5-430e-89aa-40a0367c637e | 2024-02-07 | Warnings | V13007Z41A |
| Mirakel Pain Relief Roll-On | LIDOCAINE HCL | Sanvio, Inc. | 102f3618-13ad-37e3-e063-6294a90a8086 | 2024-01-30 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.